The "cancer immunogram"

Science

Volumn 352, Issue 6286, 2016, Pages 658-660

  Blank, Christian U ^a   Haanen, John B ^a   Ribas, Antoni ^b   Schumacher, Ton N ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TUMOR MARKER;

BIOMARKER; CANCER; DISEASE TREATMENT; HISTOPATHOLOGY; IMMUNE SYSTEM; IMMUNOASSAY;

ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; CANCER IMMUNOGRAM; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; CELL INFILTRATION; DISEASE MARKER; EFFECTOR CELL; GENETIC HETEROGENEITY; HUMAN; IMMUNE RESPONSE; IMMUNE STATUS; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROBIOME; MUTATIONAL LOAD; NONHUMAN; PERSONALIZED MEDICINE; POSITIVE FEEDBACK; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; ANIMAL; IMMUNOLOGY; IMMUNOTHERAPY; MACROPHAGE; MICROFLORA; MOUSE; NEOPLASMS; PROCEDURES; TUMOR ESCAPE;

ANIMALS; BIOMARKERS, TUMOR; HUMANS; IMMUNOTHERAPY; LYMPHOCYTES, TUMOR-INFILTRATING; MACROPHAGES; MICE; MICROBIOTA; NEOPLASMS; PRECISION MEDICINE; T-LYMPHOCYTES; TUMOR ESCAPE;

EID: 84966309581     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.aaf2834     Document Type: Review

References (2)

1. References for each subsection can be found in the supplementary materials.
2. Examples of hypothetical patient cases and potential treatment options can be found in the supplementary materials.